Uterine cancer and endometrial cancer treatment

Uterine and endometrial cancer treatments at Penn Medicine

At Penn Medicine, we offer a comprehensive cancer program that provides a range of options for treating uterine and endometrial cancer. Our gynecologic oncologists are board certified in obstetrics and gynecology and have completed additional training required for treating cancer. This training includes all currently available forms of uterine cancer treatment, including surgery, radiation therapy, chemotherapy and clinical trials.

Our gynecologic oncologists will communicate regularly with other Penn specialists and members of your care team to provide comprehensive, integrated care. Our oncofertility program is experienced in creating fertility-sparing treatment plans when current or future pregnancy is a consideration.

Chemotherapy and immunotherapy for uterine cancer and endometrial cancer

Surgery for uterine cancer and endometrial cancer

Penn Medicine is proud to be a national leader in minimally invasive surgery techniques, and our surgeons treat a high number of people with uterine and endometrial cancer.

Minimally invasive surgery can result in less pain, fewer complications, and shorter recovery time. Our surgeons’ depth of experience allows them to offer minimally invasive surgical options to people with complex medical histories or existing medical conditions, such as gastric bypass, dialysis or transplants.

Uterine cancer and endometrial cancer radiation

Radiation therapy uses high-energy X-rays to kill cancer cells. It is used in about one-third of uterine and endometrial cancer treatment plans, and is often performed after uterine cancer surgery, along with other treatments.

Radiation therapy can help to reduce the risk of uterine cancer coming back.

Penn radiation oncologists are recognized leaders in techniques that target radiation precisely to the treatment area while sparing normal tissue.

Clinical trials for uterine cancer and endometrial cancer

We are proud to offer groundbreaking clinical trials that serve patients from all over the world. The goal of our uterine cancer clinical trials, conducted by researchers in conjunction with the Perelman School of Medicine, is to provide new treatment options that may be used alone or with standard treatments.

We strongly encourage you to talk to a Penn Medicine physician to see if uterine and endometrial cancer clinical trials are available and if you might qualify for one of these cutting-edge treatments.

Clinical trials have produced:

  • Precision cancer diagnoses
  • Advanced surgical and radiation techniques
  • Successful medications
  • Improved treatment outcomes
  • Strategies to enhance quality of life and address late effects of cancer

Integrative medicine for uterine and endometrial cancer 

While conventional medicine plays a critical role in cancer treatment, integrative medicine and wellness programs can enhance your quality of life, minimize or reduce the side effects of uterine cancer and cancer treatment, and promote healing and recovery. Our integrative oncology services for uterine and endometrial cancer can supplement traditional cancer treatments.

Our cancer specialists are knowledgeable and supportive of complementary cancer treatments. We can work with you and your family to integrate supportive programs into your overall care plan while ensuring your health and safety.

Services include:

Joan Karnell Supportive Services at Pennsylvania Hospital offers an extensive variety of cancer support programs for patients and families, from diagnosis through survivorship. These programs are available at no cost to the patients treated at Pennsylvania Hospital, and some are open to patients treated elsewhere. These services include social-work counseling, nutrition counseling, psychological counseling and spiritual counseling.

The Cancer Appetite and Rehabilitation Clinic focuses on patients with loss of appetite and weight.

National Cancer Institute Designated Comprehensive Cancer Center badge on top of shot of hospital

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.